Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs ONEOK Inc. Common Stock (OKE) Price & Performance

Halozyme Therapeutics Inc. Common StockTrade
ONEOK Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Halozyme Therapeutics Inc. Common Stock vs ONEOK Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while ONEOK Inc. Common Stock trades at $89.56 (market cap $56.92B). The key difference: ONEOK Inc. Common Stock is far larger — about 4.5× Halozyme Therapeutics Inc. Common Stock's market cap, and ONEOK Inc. Common Stock pays a 4.74% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and ONEOK Inc. Common Stock for 0 Days on average.

HALOOKE
Market Cap
$12.58B$56.92B
Volume
2,179,2785,022,596
Sector
HealthEnergy
52-Week High
$115.22$97.51
52-Week Low
$61.63$64.31
Typical Hold Time
1 Days0 Days
Enterprise Value
$14.49B$89.78B
Dividend Yield
—4.74%

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HALO

No sentiment data available yet.

OKE
100% Buy0% Sell
Avg holding period · 0 Days

About Halozyme Therapeutics Inc. Common Stock

Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.

Read more on HALO →

About ONEOK Inc. Common Stock

ONEOK operates energy infrastructure for natural gas, natural gas liquids, and crude oil. Its assets include pipelines, processing facilities, storage, and related services.

Read more on OKE →